These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1427561)

  • 1. Role of asynchronous activation of the ventricular fibres by an ectopic pacemaker in the accidents, especially fibrillation, caused by Ic antiarrhythmic drugs.
    Timour Q; Aupetit JF; Loufoua-Moundanga J; Kioueh I; Omar S; Chevrel G; Faucon G
    Fundam Clin Pharmacol; 1992; 6(4-5):159-67. PubMed ID: 1427561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ischaemia-induced loss or reversal of the effects of the class I antiarrhythmic drugs on vulnerability to fibrillation.
    Aupetit JF; Loufoua-Moundanga J; Faucon G; Timour Q
    Br J Pharmacol; 1997 Feb; 120(3):523-9. PubMed ID: 9031759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disappearance with ischaemic depolarization of the antifibrillatory activity in a sodium channel blocker and appearance in calcium channel blocker.
    Bui-Xuan B; Aupetit JF; Freysz M; Loufoua-Moundanga J; Faucon G; Timour Q
    Arch Int Pharmacodyn Ther; 1996; 331(3):246-62. PubMed ID: 9124997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opposite change with ischaemia in the antifibrillatory effects of class I and class IV antiarrhythmic drugs resulting from the alteration in ion transmembrane exchanges related to depolarization.
    Aupetit JF; Bui-Xuan B; Kioueh I; Loufoua J; Frassati D; Timour Q
    Can J Physiol Pharmacol; 2000 Mar; 78(3):208-16. PubMed ID: 10721812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnesium--a profibrillatory or antifibrillatory drug depending on plasma concentration, heart rate and myocardial perfusion.
    Aupetit JF; Freysz M; Faucon G; Loufoua-Moundanga J; Coquelin H; Timour Q
    Acta Anaesthesiol Scand; 1997 Apr; 41(4):516-23. PubMed ID: 9150782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Class Ic antiarrhythmic drugs and myocardial ischaemia: study in the pig heart in situ.
    Timour Q; Aupetit JF; Loufoua-Moundanga J; Gerentes-Chassagne I; Kioueh I; Faucon G
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jun; 343(6):645-51. PubMed ID: 1944606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arrhythmogenicity of antiarrhythmic drugs and intraventricular conduction disorders: possible aggravation by myocardial ischemia--study in the porcine in situ heart.
    Aupetit JF; Timour Q; Larbre JP; Loufoua-Moundanga J; Kioueh I; Lopez M; Faucon G
    Cardiovasc Drugs Ther; 1993 Apr; 7(2):217-23. PubMed ID: 8357775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Arrhythmogenic risk of antiarrhythmic drugs: study with class Ic drugs during myocardial ischemia].
    Faucon G; Aupetit JF; Gerentes-Chassagne I; Loufoua-Moundanga J; Larbre JP; Timour Q
    Bull Acad Natl Med; 1991 Feb; 175(2):217-24; discussion 224-5. PubMed ID: 1907520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention by calcium antagonists of profibrillatory effects of class I antiarrhythmic drugs in acute myocardial ischemia: study in pig heart in situ.
    Bui-Xuan B; Aupetit JF; Freysz M; Faucon G; Timour Q
    Pharmacotherapy; 1997; 17(4):737-45. PubMed ID: 9250551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of calcium channel blockers in the prevention of ventricular fibrillation of ischemic etiology: experimental arguments].
    Timour Q; Freysz M; Aupetit JF; Loufoua J; Frassati D; Faucon G
    Bull Acad Natl Med; 1996 Jan; 180(1):215-26; discussion 226-7. PubMed ID: 8696877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac beta-adrenoreceptor activation and ventricular fibrillation under normal and ischemic conditions.
    Bui-Xuan B; Aupetit JF; Freysz M; Loufoua J; Faucon G; Timour Q
    Cardiovasc Res; 1996 Dec; 32(6):1056-63. PubMed ID: 9035900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of a beta-adrenergic receptor antagonist, propranolol, in preventing ischaemic ventricular fibrillation: dependence on heart rate and ischaemia duration.
    Aupetit JF; Frassati D; Bui-Xuan B; Freysz M; Faucon G; Timour Q
    Cardiovasc Res; 1998 Mar; 37(3):646-55. PubMed ID: 9659448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement by ischemia of the risk of cardiac disorders, especially fibrillation, in regional anesthesia with bupivacaine.
    Freysz M; Timour Q; Bertrix L; Loufoua-Moundanga J; Omar S; Faucon G
    Acta Anaesthesiol Scand; 1993 May; 37(4):350-6. PubMed ID: 8322562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative study of different classes of anti-arrhythmia agents on the vulnerability of ischemic ventricular fibrillation].
    Aupetit JF; Timour Q; Chevrel G; Omar S; Loufoua-Moundanga J; Faucon G
    Therapie; 1993; 48(4):403-7. PubMed ID: 8128424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of acute ventricular capture threshold rise associated with flecainide acetate.
    Kang TS; Yoon YW; Park S; Hong BK; Kim D; Kwon HM; Kim HS
    Yonsei Med J; 2006 Feb; 47(1):152-4. PubMed ID: 16502500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Demonstration of the fibrillatory effect of class I anti-arrhythmia agents based on the time of fibrillation onset and electrical threshold in myocardial ischemia].
    Timour Q; Aupetit JF; Loufoua-Moundanga JL; Barral-Cadière L; Freysz M; Faucon G
    Therapie; 1994; 49(4):349-53. PubMed ID: 7878603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium channel modulators and susceptibility to ischaemic ventricular fibrillation: modification of cellular calcium overload.
    Timour Q; Larbre JP; Kioueh I; Aupetit JF; Loufoua-Moundanga J; Vialle A; Faucon G
    Arch Int Pharmacodyn Ther; 1992; 315():30-46. PubMed ID: 1384452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bupivacaine hastens the ischemia-induced decrease of the electrical ventricular fibrillation threshold.
    Freysz M; Timour Q; Bertrix L; Loufoua J; Aupetit JF; Faucon G
    Anesth Analg; 1995 Apr; 80(4):657-63. PubMed ID: 7893014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of an anesthetized dog model of transient cardiac ischemia and rapid pacing: a pilot study for preclinical assessment of the potential for proarrhythmic risk of novel drug candidates.
    Damiano BP; van der Linde HJ; Van Deuren B; Somers Y; Lubomirski M; Teisman A; Gallacher DJ
    J Pharmacol Toxicol Methods; 2015; 72():72-84. PubMed ID: 25450838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of flecainide, encainide, and clofilium on ventricular refractory period extension by transcardiac shocks.
    Sweeney RJ; Gill RM; Steinberg MI; Reid PR
    Pacing Clin Electrophysiol; 1996 Jan; 19(1):50-60. PubMed ID: 8848377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.